Saphetor Company

Saphetor is a precision medicine company that specializes in genome-scale analysis using Next Generation Sequencing (NGS). Their suite of services offers clinicians data-driven solutions for faster and more accurate diagnoses, particularly for cancer and difficult-to-diagnose conditions like rare diseases or cognitive impairment. Their VarSome Suite is a set of AI-driven tools for large-scale NGS data analysis, with being a freely available community-driven project and Premium and VarSome Clinical being professional extensions for researchers and clinicians.

Headquarters: Lausanne, Vaud
Investors Number: 4
Technology: NextGen sequencing analysis
Last Funding Type: Series A
Funding Status: Early Stage Venture
Employee Number: 51-100
Total Funding: CHF6.4M
Investor Type: For Profit
Founded Date: 2014
Industry: Preclinical/Clinical Trials (CRO)
Estimated Revenue: Less than $1M